Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
US Army
Federal Trade Commission
Argus Health
Chinese Patent Office

Generated: April 19, 2018

DrugPatentWatch Database Preview

Claims for Patent: 6,143,769

« Back to Dashboard

Summary for Patent: 6,143,769
Title: Phenylacetic acid benzylamides
Abstract:The present application relates to the uses of phenylacetic acid benzylamides and new (S)(+)-2-ethoxy-4-[N-[1-2-piperidino-phenyl)-3-methyl-1-butyl]-aminocarbon ylmethyl]-benzoic acid and the salts thereof, which have valuable pharmacological properties, namely an effect on the intermediate metabolism, but particularly the effect of lowering blood sugar.
Inventor(s): Grell; Wolfgang (Biberach, DE), Hurnaus; Rudolf (Biberach, DE), Griss, deceased; Gerhart (late of Biberach, DE), Sauter; Robert (Laupheim, DE), Reiffen; Manfred (Biberach, DE), Rupprecht; Eckhard (Aulendorf-Tannhausen, DE)
Assignee: Karl Thomae GmbH (Biberach an der Riss, DE)
Application Number:08/180,587
Patent Claims: 1. Substantially optically pure (S)(+)-2-ethoxy-4[N-{1-(2-piperidino-phenyl)-3-methyl-1-butyl]aminocarbony lmethyl]-benzoic acid and the salts thereof with inorganic or organic acids or bases.

2. The compound according to claim 1 having an optical purity of at least ee=95%.

3. The compound according to claim 1 having an optical purity of at least ee=98%.

4. The physiologically acceptable salts of the compound according to claim 1 with organic or inorganic acids or bases.

5. A pharmaceutical composition comprising a compound according to claim 1 and one or more inert carriers or diluents.

6. A method for treating diabetes mellitus comprising administering a therapeutically effective amount of the compound as recited in claim 1.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
US Army
Federal Trade Commission
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.